Biotia Raises $9M From Digitaldx Ventures

Biotia raises $9M Series A+ led by DigitalDx Ventures.

Other participants included various investors that support innovative health solutions.

Biotia develops clinical metagenomics solutions. The company is led by CEO Niamh O'Hara.

The funds will be utilized to enhance its laboratory in New York City, introduce more diagnostics focusing on women's health, and broaden its reach into orthopedic diagnostics.

Company	Biotia
Round	Series A+
Amount	$9M
Lead Investor	DigitalDx Ventures
Founders	Niamh O'Hara (CEO, cofounder), Chris Mason (global director
Sectors	healthcare